Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Alx Oncology Holdings Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +13 vs. Q4 2023
- Shares held
- 45.8M
- +21.5K (0.0%) vs. Q4 2023
- Total value
- $510.5M
- −$171.0M (−25.1%) vs. Q4 2023
- New holders
- 23
- 28 more added
- Sold out
- 10
- 31 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALXO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 93 | $217.9M |
| Q1 2026 | 69 | $189.0M |
| Q4 2025 | 57 | $33.0M |
| Q3 2025 | 61 | $50.8M |
| Q2 2025 | 61 | $12.1M |
| Q1 2025 | 85 | $21.7M |
| Q4 2024 | 87 | $68.5M |
| Q3 2024 | 92 | $82.7M |
| Q2 2024 | 112 | $293.4M |
| Q1 2024 | 106 | $510.5M |
| Q4 2023 | 93 | $681.5M |
| Q3 2023 | 76 | $159.8M |
| Q2 2023 | 75 | $257.5M |
| Q1 2023 | 86 | $161.4M |
| Q4 2022 | 87 | $410.6M |
| Q3 2022 | 99 | $348.7M |
| Q2 2022 | 97 | $290.7M |
| Q1 2022 | 96 | $621.9M |
| Q4 2021 | 108 | $780.0M |
| Q3 2021 | 115 | $2.55B |
| Q2 2021 | 105 | $1.82B |
| Q1 2021 | 94 | $2.47B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Alx Oncology Holdings Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 2,717,970 | $30.3M | 0.59% | −377,030−12.2% | Reduced |
| Cormorant Asset Management, LP | 3,142,079 | $35.0M | 1.54% | 00.0% | Unchanged |
| Vivo Capital, LLC | 4,220,048 | $47.1M | 3.70% | 00.0% | Unchanged |
| Redmile Group, LLC | 4,326,509 | $48.2M | 1.77% | +667,245+18.2% | Added |
| FMR LLC | 7,522,812 | $83.9M | 0.01% | +49,991+0.7% | Added |
| venBio Partners LLC | 9,699,925 | $108.2M | 38.37% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −913,700−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −385,232−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −104,600−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −65,814−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −50,178−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −23,032−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −17,793−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −14,389−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −10,708−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,600−100.0% | Sold out |